Ọnwụ ọnwụ Semaglutide CAS 910463-68-2
Nkọwa
Semaglutide (910463-68-2) bụ ọgwụ mgbochi ọrịa shuga nke a na-ere n'okpuru aha aha dịka Ozempic, Wegovy, na Rybelsus.A na-eji ya agwọ ụdị ọrịa shuga 2 ma jikwaa ibu na-adịghị ala ala.Ọgwụ a na-arụ ọrụ dị ka glucagon-dị ka peptide-1 (GLP-1) mmadụ site na ịba ụba nke insulin, nke na-eduga n'ịbawanye shuga metabolism.A na-ekesa ya dị ka ntụtụ subcutaneous metered n'ime mkpịsị odee emejuru, ma ọ bụ dị ka ụdị ọnụ.Otu n'ime uru ya karịa ọgwụ antidiabetic ndị ọzọ bụ na ọ na-arụ ọrụ ogologo oge, ya mere, naanị otu ugboro n'izu zuru ezu.
Na-eji
A na-eji Semaglutide ejikwa ụdị ọrịa shuga 2 yana mgbanwe ndụ, dị ka mmachi nri na ịba ụba anụ ahụ.Ọ na-arụkwa ọrụ site n'ibelata mmegharị nke nri site n'afọ ma nwee ike ibelata agụụ ma bute ibu ibu.Enwebeghị akụkọ ebipụtara maka hepatotoxicity sitere na ọgwụgwọ semaglutide.
Usoro nke ime ihe
Semaglutide bụ glucagon-dị ka peptide-1 agonist nnabata.Ọ na-abawanye mmepụta insulin, hormone nke na-ebelata ọkwa shuga dị n'ọbara.Ọ dịkwa ka ọ na-abawanye uto mkpụrụ ndụ β na pancreas, bụ ebe a na-emepụta insulin.Ọ na-egbochikwa glucagon, nke bụ homonụ na-abawanye shuga ọbara.Ọ na-ebelatakwa iri nri site na ibelata agụụ ma na-ebelata mgbaze na afọ.N'ụzọ dị otú a, ọ na-ebelata abụba anụ ahụ.
Omume ndu
Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), ihe analog nke glucagon dị ka peptide 1 (GLP-1) na-eme ogologo oge, bụ onye na-anabata GLP-1 nwere ike ịgwọ ụdị ọrịa shuga mellitus 2. (T2DM).
Nkwakọ ngwaahịa & nnyefe
